|
|
Robotic assisted radical prostatectomy accelerates postoperative stress recovery: Final results of a contemporary prospective study assessing pathophysiology of cortisol peri-operative kinetics in prostate cancer surgery |
Antonio B. Porcaroa, Nicolò de Luyka, Paolo Corsia, Marco Sebbena, Alessandro Tafuria, Davide Inverardia, Davide De Marchia, Irene Tamaninia, Matteo Brunellib, Maria Angela Cerrutoa, Gian Luca Salvagnoc, Gian Cesare Guidic, Walter Artibania
|
a Urologic Clinic, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, Italy;
b Department of Pathology, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, Italy;
c Department of Laboratory Medicine, University Hospital, Ospedale Policlinico, Azienda Ospedaliera Universitaria Integrata, Verona, Italy |
|
|
Abstract Objective: To investigate the effects of prostate cancer (PCa) surgery on the stress system and to identify potential independent factors associating with stress recovery.
Methods: The design of the study was prospective and PCa surgery included robot assisted radical prostatectomy (RARP) or retropubic radical prostatectomy (RRP). Between February 2013 to December 2014, 315 consecutive patients were evaluated. The effects of PCa surgery on the stress system were measured by cortisol serum levels before and after surgery on postoperative day (POD) 0, 1, 3, 5 and 45. Cortisol variations in the population and subpopulation (RARP vs. RRP) of patients were investigated by statistical methods. Factors associating with stress recovery were assessed by simple linear regression (SLR) and multiple linear regression (MLR) analysis.
Results: RARP was performed in 75.9% of cases. In the patient population, there were wide serum cortisol perioperative variations. PCa surgery triggered the stress system which immediately (POD 0) responded by cortisol overproduction which induced the negative feedback mechanism that started on POD 1, continued on POD 3, was still ongoing on POD 5 and completely settled on POD 45 (stress recovery). In the subpopulation of patients, significantly lower cortisol serum levels were detected on POD 3-5 in RARP cases inwhomcortisol levels were close to preoperative levels (stress recovery) on POD 5. Independent predictive factors of serum cortisol on POD 5 (stress recovery) were preoperative cortisol (p=0.02), cortisol levels on POD 3 (p < 0.0001) and RARP (p=0.03) in which the association was negative (stress recovery faster than RRP).
Conclusion: Our study shows that PCa surgery immediately (POD 0) triggers the stress system which respond by overproduction of cortisol which induces the negative feedback mechanism that starts on POD 1, is still ongoing on POD 5, but is completely settled on POD 45. Moreover, after surgical trauma, our study gives evidence that the RARP procedure associates with stress recovery faster than RRP. Further confirmatory studies are required.
|
Received: 03 September 2015
Published: 13 May 2016
|
Corresponding Authors:
Antonio B. Porcaro
E-mail: drporcaro@yahoo.com
|
|
|
[1] |
Siegel R, Niashadham D, Jemal A. Cancer statistic, 2012. CA Cancer J Clin 2012;62:10-29.
|
[2] |
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.
|
[3] |
HeidenreichA, Bellmunt J, BollaM, JoniauS,MasonM,Matveev V, et al., European Association of Urology. EAU guidelines on prostate cancer. Part 1:screening, diagnosis, and treatment of clinically localized disease. Eur Urol 2011;59:61-71.
|
[4] |
Mullins JK, Feng Z, Trock BJ, Epstein JI, Walsh PC, Loeb S. The impact of anatomical radical prostatectomy on cancer control:the 30-year anniversary. J Urol 2012;188:2219-24.
|
[5] |
Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carrol PR, et al., Pasadena Consensus Panel. Best practices in robot-assisted radical prostatectomy:recommendations of the Pasadena Consensus Panel. Eur Urol 2012;62:368-81.
|
[6] |
Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg 2006;141:1132-40.
|
[7] |
Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-52.
|
[8] |
Tsigos C, Chrousos GP. Hypothalamicepituitaryeadrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002;53:865-71.
|
[9] |
Gibbison B, Angelini GD, Lightman L. Dynamic output and control of the hypothalamic-pituitary-adrenal axis in critical illness and major surgery. Br J Anesth 2013;111:347-60.
|
[10] |
Fracalanza S, Ficarra V, Cavalleri S, Galfano A, Novara G, Mangano A, et al. Is robotically assisted laparoscopic radically prostatectomy less invasive than retropubic radical prostatectomy? Results from a prospective, unrandomized, comparative study. BJU Int 2008;101:1145-9.
|
[11] |
Menon M, Tewari A, Peabody J, The VIP Team. Vattikuti Institute prostatectomy:technique. J Urol 2003;169:2289-92.
|
[12] |
Walsh PC. Anatomic radical retropubic prostatectomy. In:Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's urology. 8th ed. Philadelphia:WB Saunders; 2002. p. 3107-29.
|
[13] |
D'Amico AV, Whittington R, Malkowicz SB, Shultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-74.
|
[14] |
Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection:the essential importance of percentage of positive cores. Eur Urol 2012;61:480-7.
|
[15] |
Dripps RD, Lamont A, Eckenhoff J. The role of anesthesia in surgical mortality. JAMA 1961;178:261-3.
|
[16] |
Dindo D, Demartines N, Clavien PA. Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.
|
[17] |
Flemming ID, Cooper JS, Henson DE, Hutte RVP, Kennedy BJ, Murphy GP, et al., editors. American Joint Committee on Cancer Staging Manual. 5th ed. Philadelphia:JP Lippincott; 1997. p. 219-22.
|
[18] |
Roberts FS, Roberts WL. Performance characteristics of five automated serum cortisol immunoassays. Clin Biochem 2004; 37:489-93.
|
[19] |
Eisold S, Mehrabi A, Konstantinidis L, Mieth M, Hinz H, Kashfi A, et al. Experimental study of cardiorespiratory stress factors in esophageal surgery using robot-assisted thoracoscopic or open thoracic approach. Arch Surg 2008;143:156-63.
|
[20] |
Porcaro AB, Molinari A, Terrin A, De Luyk N, Bldassarre R, Brunelli M, et al. Robotic-assisted radical prostatectomy is less stressful than the open approach:results of a contemporary prospective study evaluating pathophysiology of cortisol stress-related kinetics in prostate cancer surgery. J Robot Surg 2015;9:249-55.
|
[1] |
S. Sfanos Karen,Yegnasubramanian Srinivasan,G. Nelson William,L. Lotan Tamara,Kulac Ibrahim,L. Hicks Jessica,Zheng Qizhi,J. Bieberich Charles,C. Haffner Michael,M. De Marzo Angelo. If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease[J]. Asian Journal of Urology, 2019, 6(1): 10-25. |
[2] |
Dong Liang,C. Zieren Richard,Xue Wei,M. de Reijke Theo,J. Pienta Kenneth. Metastatic prostate cancer remains incurable, why?[J]. Asian Journal of Urology, 2019, 6(1): 26-41. |
[3] |
M. Armstrong Cameron,C. Gao Allen. Current strategies for targeting the activity of androgen receptor variants[J]. Asian Journal of Urology, 2019, 6(1): 42-49. |
[4] |
B. Isaacs William,Xu Jianfeng. Current progress and questions in germline genetics of prostate cancer[J]. Asian Journal of Urology, 2019, 6(1): 3-9. |
[5] |
Etheridge Tyler,Damodaran Shivashankar,Schultz Adam,A. Richards Kyle,Gawdzik Joseph,Yang Bing,Cryns Vincent,F. Jarrard David. Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier[J]. Asian Journal of Urology, 2019, 6(1): 57-64. |
[6] |
Chia-Yi Chu Gina,W.K. Chung Leland,Gururajan Murali,Hsieh Chia-Ling,Josson Sajni,Nandana Srinivas,Sung Shian-Ying,Wang Ruoxiang,Boyang Wu Jason,E. Zhau Haiyen. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics[J]. Asian Journal of Urology, 2019, 6(1): 65-81. |
[7] |
Dicken Haley,J. Hensley Patrick,Kyprianou Natasha. Prostate tumor neuroendocrine differentiation via EMT: The road less traveled[J]. Asian Journal of Urology, 2019, 6(1): 82-90. |
[8] |
Xu Lingfan,Chen Junyi,Liu Weipeng,Liang Chaozhao,Hu Hailiang,Huang Jiaoti. Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer[J]. Asian Journal of Urology, 2019, 6(1): 91-98. |
[9] |
Chen Shulian,Gao Rang,Li Hong,Wang Kunjie. Management of acquired rectourethral fistulas in adults[J]. Asian Journal of Urology, 2018, 5(3): 149-154. |
[10] |
Chen Kenneth,Jack Tay Kae,Mee Law Yan,Aydin Hakan,Ho Henry,Cheng Christopher,Shyi Peng Yuen John. Outcomes of combination MRI-targeted and transperineal template biopsy in restaging low-risk prostate cancer for active surveillance[J]. Asian Journal of Urology, 2018, 5(3): 184-193. |
[11] |
Su Jiarui,Jonathan Aslim Edwin,Aydin Hakan,HoonTan Puay,Sun SienHo Henry. A rare case of isolated castrate resistant bilateral testicular metastases in advanced prostate cancer[J]. Asian Journal of Urology, 2018, 5(2): 127-130. |
[12] |
Per-Anders Abrahamsson. Intermittent androgen deprivation therapy in patients with prostate cancer:Connecting the dots[J]. Asian Journal of Urology, 2017, 4(4): 208-222. |
[13] |
Yoshiyasu Amiya, Yasutaka Yamada, Masahiro Sugiura, Makoto Sasaki, Takayuki Shima, Noriyuki Suzuki, Hiroomi Nakatsu, Shino Murakami, Jun Shimazaki. Outcomes of patients older than 75 years with non-metastatic prostate cancer[J]. Asian Journal of Urology, 2017, 4(2): 102-106. |
[14] |
Dingwei Ye, Yiran Huang, Fangjian Zhou, Keji Xie, Vsevolod Matveev, Changling Li, Boris Alexeev, Ye Tian, Mingxing Qiu, Hanzhong Li, Tie Zhou, Peter De Porre, Margaret Yu, Vahid Naini, Hongchuan Liang, Zhuli Wu, Yinghao Sun. A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapynaïve patients with mCRPC in China, Malaysia, Thailand and Russia[J]. Asian Journal of Urology, 2017, 4(2): 75-85. |
[15] |
Kai Zhang, Chris H. Bangma, Monique J. Roobol. Prostate cancer screening in Europe and Asia[J]. Asian Journal of Urology, 2017, 4(2): 86-95. |
|
|
|
|